Research & Development

Innovation is an integral part of our DNA.

Research & Development

Innovation is an integral part of our DNA.

Our R&D unit

One of the priorities of our R&D team is to provide precise, reliable and relevant dosimetric information. Our goal: meet the expectations of medical and paramedical teams in their clinical routine, as well as those of scientific partners.
To achieve this, our team of experts is always ready to listen to our customers’ needs, and includes them in our discussions on product and service improvements.

Our know-how

Dosimetry

Medical Physics

Scintillating optical fiber

Connected devices

Software

Smart data

Our R&D unit focuses on

Our industrial partners
To develop our detectors, we make it a point of honour to work with French and local companies.

SEDI-ATI, Cintech,Weil Industries, ATTA02, Alfacem
Fundamental research

We are pooling our expertise in physics with Neolys Diagnostics to enable better assessment of the radiation-induced risk to patients and workers exposed to ionizing radiation in real-life exposure situations.

A study in progress aims to map the biological effects and associated dose of image-guided radiotherapy treatments (CBCT). This work will enable us to better understand the effects of low doses of radiation encountered in medical radiodiagnostics, and to establish clinical recommendations according to the type of patient concerned (radiosensitivity / radio-susceptibility).

Multicentric characterization of organ-based tube current modulation in head computed tomography: A dosimetric and image quality study
PONDARD S, DESPORT C, MUNIER M, KIEN N, ROUSSEAU H, MERIGNAC O, POPOTTE C, MORENO R
Phys Med . 2024 Jun:122:103389. doi: 10.1016/j.ejmp.2024.103389. Epub 2024 May 30.
Previous slide
Next slide

We use cookies to guarantee you the best experience on our website. By continuing to use this site you agree to this use. See our privacy policy.